SWK Holdings to Present at Two Upcoming Investor Conferences
SWK Holdings Corporation (Nasdaq: SWKH) announced that its chairman and CEO, Winston Black, will present at two upcoming investor conferences. The Virtual Life Science Investor Forum is scheduled for September 17, 2020, at 12:00 PM (ET), with a live webcast available at this link. Additionally, the Financial Services Investor Conference will take place on September 24, 2020, at 10:30 AM (ET), with a livestream at this link. Investors can also access these events on the company's website.
- None.
- None.
DALLAS, Sept. 15, 2020 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life science focused specialty finance company, today announced that its chairman and chief executive officer, Winston Black, will present at two upcoming investor conferences.
Details of SWK Holdings's presentations are as follows:
Event: | Virtual Life Science Investor Forum | |
Date: | Thursday, September 17, 2020 | |
Time: | 12:00 PM (ET) | |
Live Webcast: | ||
Event: | Financial Services Investor Conference | |
Date: | Thursday, September 24, 2020 | |
Time: | 10:30 AM (ET) | |
Live Webcast: |
The live webcast of each presentation will available by clicking the provided link above or by viewing upcoming events under the Investor Relations section of the Company's website at www.swkhold.com.
About SWK Holdings:
SWK Holdings Corporation is a specialized finance company with a focus on the global healthcare sector. SWK partners with ethical product marketers and royalty holders to provide flexible financing solutions at an attractive cost of capital to create long-term value for both SWK's business partners and its investors. SWK believes its financing structures achieve an optimal partnership for companies, institutions and inventors seeking capital for expansion or capital and estate planning by allowing its partners to monetize future cash flow with minimal dilution to their equity stakes. SWK also owns Enteris Biopharma, whose core Peptelligence™ drug delivery technology creates oral formulations of peptide-based and BCS class II, III, and IV small molecules. With Enteris, SWK has the opportunity to grow its specialty finance business by actively building a wholly-owned portfolio of milestones and royalties through licensing activities. Additional information on the life science finance market is available on the Company's website at www.swkhold.com.
Safe Harbor Statement
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements including words such as "believes," "expects," "anticipates," "intends," "estimates," "plan," "will," "may," "look forward," "intend," "guidance," "future" or similar expressions are forward-looking statements. Because these statements reflect SWK's current views, expectations and beliefs concerning future events, these forward-looking statements involve risks and uncertainties. Investors should note that many factors, as more fully described under the caption "Risk Factors" and elsewhere in SWK's Form 10-K, Form 10-Q and Form 8-K filings with the Securities and Exchange Commission and as otherwise enumerated herein, could affect the Company's future financial results and could cause actual results to differ materially from those expressed in such forward-looking statements. The forward-looking statements in this press release are qualified by these risk factors. These are factors that, individually or in the aggregate, could cause the Company's actual results to differ materially from expected and historical results. You should not place undue reliance on any forward-looking statements, which speak only as of the date they are made. We assume no obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise.
View original content:http://www.prnewswire.com/news-releases/swk-holdings-to-present-at-two-upcoming-investor-conferences-301131447.html
SOURCE SWK Holdings Corporation
FAQ
What are the dates of SWK Holdings' upcoming investor presentations?
What times will SWK Holdings present at the investor conferences?
How can I access the webcasts for SWK Holdings' investor presentations?
Who is presenting for SWK Holdings at the investor conferences?
What is the stock symbol for SWK Holdings?
